Then David, who leads the Factor XI clinical program at Regeneron, will present preclinical data as well as clinical data from the ROXI-VTE-I and II studies in venous thromboembolism prevention post ...
The damage of strokes caused by brain bleeds can be mitigated by removing dead blood cells. Scientists have now found a way ...
A Nashville-based medical company that credits half its business to IV therapy is expanding into Birmingham after celebrating ...